Clayton Partners LLC - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 49 filers reported holding SOLENO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
Clayton Partners LLC ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$167,000
+32.5%
100,0000.0%0.19%
+54.1%
Q1 2021$126,000100,0000.12%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$19,884,0006.80%
Trellus Management Company, LLC 662,612$1,279,0001.06%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$7,084,0000.89%
CVI Holdings, LLC 1,550,960$2,993,0000.56%
Nantahala Capital Management 7,871,356$15,192,0000.47%
AWM Investment Company, Inc. 1,550,000$2,991,0000.38%
SILVERARC CAPITAL MANAGEMENT, LLC 322,798$623,0000.36%
Granite Point Capital Management, L.P. 1,926,594$3,718,0000.19%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,758,200$11,113,0000.16%
Greylin Investment Management, Inc 113,195$218,0000.05%
View complete list of SOLENO THERAPEUTICS INC shareholders